Evidence map›Paper›PMID 41253795›Full record

ArticleNPJ genomic medicine2025

RareLink: scalable REDCap-based framework for rare disease interoperability linking international registries to FHIR and Phenopackets.

Adam S L Graefe, Filip Rehburg, Samer Alkarkoukly, Daniel Danis, Ana Grönke, Miriam R Hübner, Alexander Bartschke, Thomas Debertshäuser, Sophie A I Klopfenstein, Julian Saß and 18 more

Abstract read
In one paragraph

Article in NPJ genomic medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. A Phenotypic Paradigm for Cerebral Palsy Genetics.medRxiv : the preprint server for health sciences · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Adam S L GraefeBerlin Institute of Health at Charité‒Universitätsmedizin Berlin, Berlin, Germany. adam.graefe@charite.de.ORCID http://orcid.org/0009-0004-8124-8864
Filip RehburgBerlin Institute of Health at Charité‒Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0009-0007-0457-5724
Samer AlkarkouklyMedical Data Integration Center (MeDIC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0003-1891-1366
Daniel DanisBerlin Institute of Health at Charité‒Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0003-0900-3411
Ana GrönkeMedical Data Integration Center (MeDIC), University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.ORCID http://orcid.org/0009-0006-9447-7687
Miriam R HübnerBerlin Institute of Health at Charité‒Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0001-5160-1242
Alexander BartschkeBerlin Institute of Health at Charité‒Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-5849-482X
Thomas DebertshäuserBerlin Institute of Health at Charité‒Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0009-0005-9329-2675
Sophie A I KlopfensteinBerlin Institute of Health at Charité‒Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-8470-2258
Julian SaßBerlin Institute of Health at Charité‒Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-2068-7765
Julia FleckCenter for Rare Diseases, Medical Faculty, RWTH Aachen University, Aachen, Germany.ORCID http://orcid.org/0000-0003-2766-4547
Mirko RehbergDepartment of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany, Cologne, Germany.ORCID http://orcid.org/0000-0001-9534-4102
Jana ZschüntzschDepartment of Neurology, University Medical Center Goettingen, Goettingen, Germany.ORCID http://orcid.org/0000-0002-7062-5319
Elisabeth F NyounguiDepartment of Medical Informatics, University Medical Center Goettingen, Goettingen, Germany.ORCID http://orcid.org/0000-0003-4263-4629
Tatiana KalashnikovaSection of Hematology and Immunology, Alberta Children's Hospital, Calgary, Canada.ORCID http://orcid.org/0009-0009-3825-144X
Luis Murguía-FavelaSection of Hematology and Immunology, Alberta Children's Hospital, Calgary, Canada.ORCID http://orcid.org/0000-0001-6893-3366
Beata DerfalviDepartment of Pediatrics, Division of Immunology, Dalhousie University, IWK Health, Halifax, NS, Canada.ORCID http://orcid.org/0000-0001-7272-7119
Nicola A M WrightSection of Hematology and Immunology, Alberta Children's Hospital, Calgary, Canada.ORCID http://orcid.org/0000-0003-3144-4969
Shahida MoosaDivision of Molecular Biology and Human Genetics, Stellenbosch University, Cape Town, South Africa.ORCID http://orcid.org/0000-0002-4463-3067
Soichi OgishimaINGEM, Tohoku University, Sendai, Miyagi, Japan.ORCID http://orcid.org/0000-0001-8613-2562
Oliver SemlerDepartment of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne University of Cologne Cologne Germany, Cologne, Germany.ORCID http://orcid.org/0000-0003-0029-7556
Susanna WiegandDepartment of Pediatric Endocrinology and Diabetology, Charité University Hospital, Berlin, Germany.ORCID http://orcid.org/0000-0001-8341-9533
Peter KühnenDepartment of Pediatric Endocrinology and Diabetology, Charité University Hospital, Berlin, Germany.ORCID http://orcid.org/0000-0003-0211-176X
Christopher J MungallDivision of Environmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-6601-2165
Melissa A HaendelDepartment of Genetics, University of North Carolina Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0001-9114-8737
Peter N RobinsonBerlin Institute of Health at Charité‒Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-0736-9199
Sylvia ThunBerlin Institute of Health at Charité‒Universitätsmedizin Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-3346-6806
Oya BeyanInstitute for Biomedical Informatics, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0001-7611-3501

Funding

The Monarch Initiative: Linking Diseases to Model Organism ResourcesR24OD011883 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAENDEL, MELISSA A, MUNGALL, CHRISTOPHER J · 2012 to 2024
$16.0M
Improvements to the LinkML framework to support the Phenomics First open science resourceRM1HG010860 · NHGRI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAENDEL, MELISSA A, MUNGALL, CHRISTOPHER J · 2020 to 2024
$10.3M
The Human Phenotype Ontology: Accelerating Computational Integration of Clinical Data for GenomicsU24HG011449 · NHGRI · JACKSON LABORATORY · PI Peter Nicholas Robinson · 2021 to 2026
$6.7M
German Federal Ministry of Education and Research BMBF; FKZ 01KX2121German Research Foundation DFG FOR 2722; ref. SE2373/1-2; project 384170921NHGRI NIH HHS RM1 HG010860NHGRI NIH HHS U24 HG011449NIH HHS R24 OD011883U.S. National Institutes of Health, National Human Genome Research Institute grant 7RM1HG010860U.S. NIH NHGRI grant 5U24HG011449
6 · The paper itself

Abstract

While Research Electronic Data Capture (REDCap) is widely adopted in rare disease research, its unconstrained data format often lacks native interoperability with global health standards, limiting secondary use. We developed RareLink, an open-source framework implementing our published ontology-based rare disease common data model. It enables standardised data exchange between REDCap, international registries, and downstream analysis tools by linking Global Alliance for Genomics and Health Phenopackets and Health Level 7 Fast Healthcare Interoperability Resources (FHIR) instances conforming to International Patient Summary and Genomics Reporting profiles. RareLink was developed in three phases across Germany, Canada, South Africa, and Japan for registry and data analysis purposes. We defined a simulated Kabuki syndrome cohort and demonstrated data export to Phenopackets and FHIR. RareLink can enhance the clinical utility of REDCap through its global applicability, supporting equitable rare disease research. Broader adoption and coordination with international entities are thus essential to realise its full potential.

Identifiers

PMID41253795
PMCPMC12627670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.